These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2471228)

  • 1. Substance P involved in mental disorders.
    Takeuchi K; Uematsu M; Ofuji M; Morikiyo M; Kaiya H
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12 Suppl():S157-64. PubMed ID: 2471228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
    Shirayama Y; Mitsushio H; Takahashi K; Nishikawa T
    Synapse; 2000 Mar; 35(4):292-9. PubMed ID: 10657039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin: role in psychiatric and neurological diseases.
    Cáceda R; Kinkead B; Nemeroff CB
    Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The substance P (SP) heptapeptide fragment SP1-7 alters the density of dopamine receptors in rat brain mesocorticolimbic structures during morphine withdrawal.
    Zhou Q; Kindlundh AM; Hallberg M; Nyberg F
    Peptides; 2004 Nov; 25(11):1951-7. PubMed ID: 15501527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of serotonin transmission in schizophrenia.
    Abi-Dargham A
    Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?
    Cáceda R; Kinkead B; Nemeroff CB
    Semin Clin Neuropsychiatry; 2003 Apr; 8(2):94-108. PubMed ID: 12728409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development.
    Marek GJ
    Int Rev Neurobiol; 2007; 78():165-92. PubMed ID: 17349861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications.
    Constantinidis J; Bouras C; Richard J
    Clin Neuropathol; 1983; 2(2):47-54. PubMed ID: 6189657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Substance P].
    Cesaro P
    Rev Neurol (Paris); 1984; 140(8-9):465-78. PubMed ID: 6208589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of substance P in stress and anxiety responses.
    Ebner K; Singewald N
    Amino Acids; 2006 Oct; 31(3):251-72. PubMed ID: 16820980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide metabolism on intact, regional brain slices: effect of dopaminergic agents on substance P, cholecystokinin and Met-enkephalin degradation.
    Waters SM; Konkoy CS; Davis TP
    J Pharmacol Exp Ther; 1995 Aug; 274(2):783-9. PubMed ID: 7543572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia.
    Carletti R; Corsi M; Melotto S; Caberlotto L
    Eur J Neurosci; 2005 Mar; 21(6):1712-8. PubMed ID: 15845098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic nicotine treatment differentially regulates substance P and tyrosine hydroxylase immunoreactivity in substantia nigra ipsilateral to a unilateral lesion.
    Janson AM; Fuxe K
    Exp Neurol; 1997 Aug; 146(2):575-86. PubMed ID: 9270071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of GABA and substance P on metabolism of striatal dopamine following experimental cerebral ischemia].
    Li QY
    Zhonghua Yi Xue Za Zhi; 1993 Nov; 73(11):677-9, 702. PubMed ID: 7510213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of central glutamatergic neurotransmission in the pathogenesis of psychiatric and behavioral disorders.
    Wang SJ; Yang TT
    Drug News Perspect; 2005 Nov; 18(9):561-6. PubMed ID: 16421629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Various achievements of modern neurophysiology in the area of psychiatry (review of the foreign literature)].
    Paniushkina SV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1229-32. PubMed ID: 6118985
    [No Abstract]   [Full Text] [Related]  

  • 20. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.